Acute Renal Failure Clinical Presentation
- Author: Biruh T Workeneh, MD; Chief Editor: Vecihi Batuman, MD, FACP, FASN more...
History
A detailed and accurate history is crucial to the diagnosis of the type of acute kidney injury (AKI) that a patient has and to determining the disease’s subsequent treatment.
Distinguishing AKI from chronic renal failure is important, yet making the distinction can be difficult. A history of chronic symptoms—fatigue, weight loss, anorexia, nocturia, and pruritus—suggests chronic renal failure.
Take note of the following findings during the physical examination:
- Hypotension
- Volume contraction
- Congestive heart failure
- Nephrotoxic drug ingestion
- History of trauma or unaccustomed exertion
- Blood loss or transfusions
- Evidence of connective tissue disorders or autoimmune diseases
- Exposure to toxic substances, such as ethyl alcohol or ethylene glycol
- Exposure to mercury vapors, lead, cadmium, or other heavy metals, which can be encountered in welders and miners
People with the following comorbid conditions are at a higher risk for developing AKI:
- Hypertension
- Congestive cardiac failure
- Diabetes
- Multiple myeloma
- Chronic infection
- Myeloproliferative disorder
Urine output history can be useful. Oliguria generally favors AKI. Abrupt anuria suggests acute urinary obstruction, acute and severe glomerulonephritis, or embolic renal artery occlusion. A gradually diminishing urine output may indicate a urethral stricture or bladder outlet obstruction due to prostate enlargement.
Because of a decrease in functioning nephrons, even a trivial nephrotoxic insult may cause AKI to be superimposed on chronic renal insufficiency.
Acute kidney injury (AKI) has a long differential diagnosis. History can help classify the pathophysiology of AKI as prerenal, intrinsic renal, or postrenal failure, and it may suggest some specific etiologies.
Prerenal failure
Patients commonly present with symptoms related to hypovolemia, including thirst, decreased urine output, dizziness, and orthostatic hypotension.
Elders with vague mental status change are commonly found to have prerenal or normotensive ischemic AKI.
Ask about volume loss from vomiting, diarrhea, sweating, polyuria, or hemorrhage.
Patients with advanced cardiac failure leading to depressed renal perfusion may present with orthopnea and paroxysmal nocturnal dyspnea.
Insensible fluid losses can result in severe hypovolemia in patients with restricted fluid access and should be suspected in elderly patients and in comatose or sedated patients.
Intrinsic renal failure
Patients can be divided into those with glomerular etiologies and those with tubular etiologies of AKI.
Nephritic syndrome of hematuria, edema, and HTN indicates a glomerular etiology of AKI. Query about prior throat or skin infections.
ATN should be suspected in any patient presenting after a period of hypotension secondary to cardiac arrest, hemorrhage, sepsis, drug overdose, or surgery.
A careful search for exposure to nephrotoxins should include a detailed list of all current medications and any recent radiologic examinations (ie, exposure to radiologic contrast agents).
Pigment-induced AKI should be suspected in patients with possible rhabdomyolysis (muscular pain, recent coma, seizure, intoxication, excessive exercise, limb ischemia) or hemolysis (recent blood transfusion).
Allergic interstitial nephritis should be suspected with fevers, rash, arthralgias, and exposure to certain medications, including NSAIDs and antibiotics.
Postrenal failure
Postrenal failure usually occurs in older men with prostatic obstruction and symptoms of urgency, frequency, and hesitancy. Patients may present with asymptomatic, high-grade urinary obstruction because of the chronicity of their symptoms.
A history of prior gynecologic surgery or abdominopelvic malignancy often can be helpful in providing clues to the level of obstruction.
Flank pain and hematuria should raise a concern about renal calculi or papillary necrosis as the source of urinary obstruction.
Use of acyclovir, methotrexate, triamterene, indinavir, or sulfonamides implies the possibility of tubular obstruction by crystals of these medications.
Physical Examination
Obtaining a thorough physical examination is extremely important when collecting evidence about the etiology of acute kidney injury (AKI).
Skin
Skin examination may reveal the following:
- Livido reticularis, digital ischemia, butterfly rash, palpable purpura - Systemic vasculitis
- Maculopapular rash - Allergic interstitial nephritis
- Track marks (ie, intravenous drug abuse) - Endocarditis
Petechiae, purpura, ecchymosis, and livedo reticularis provide clues to inflammatory and vascular causes of AK.
Infectious diseases, TTP, DIC, and embolic phenomena can produce typical cutaneous changes.
Eyes
Eye examination may reveal the following:
- Keratitis, iritis, uveitis, dry conjunctivae - Autoimmune vasculitis
- Jaundice - Liver diseases
- Band keratopathy (ie, hypercalcemia) - Multiple myeloma
- Signs of diabetes mellitus
- Signs of hypertension
- Atheroemboli (retinopathy)
Evidence of uveitis may indicate interstitial nephritis and necrotizing vasculitis.
Ocular palsy may indicate ethylene glycol poisoning or necrotizing vasculitis.
Findings suggestive of severe hypertension, atheroembolic disease, and endocarditis may be observed on careful examination of the eyes.
Ears
Ear examination may reveal the following:
- Hearing loss - Alport disease and aminoglycoside toxicity
- Mucosal or cartilaginous ulcerations - Wegener granulomatosis
Cardiovascular system
Cardiovascular examination may reveal the following:
- Irregular rhythms (ie, atrial fibrillation) - Thromboemboli
- Murmurs - Endocarditis
- Increased jugulovenous distention, rales, S3 - CHF
The most important part of the physical examination is the assessment of cardiovascular and volume status.
The physical examination must include pulse rate and blood pressure recordings measured in the supine position and the standing position; close inspection of the jugular venous pulse; careful examination of the heart, lungs, skin turgor, and mucous membranes; and assessment for the presence of peripheral edema.
In hospitalized patients, accurate daily records of fluid intake and urine output and daily measurements of patient weight are important. Hypovolemia leads to hypotension; however, hypotension may not necessarily indicate hypovolemia.
Severe CHF may also cause hypotension. Although patients with CHF may have low blood pressure, volume expansion is present and effective renal perfusion is poor, which can result in AKI.
Severe hypertension with renal failure suggests renovascular disease, glomerulonephritis, vasculitis, or atheroembolic disease.
Abdomen
Abdominal examination may reveal the following:
- Pulsatile mass or bruit - Atheroemboli
- Abdominal or costovertebral angle tenderness - Nephrolithiasis, papillary necrosis, renal artery thrombosis, renal vein thrombosis
- Pelvic, rectal masses; prostatic hypertrophy; distended bladder – Urinary obstruction
- Limb ischemia, edema - Rhabdomyolysis
Abdominal examination findings can be useful to help detect obstruction at the bladder outlet as the cause of renal failure, which may be due to cancer or an enlarged prostate.
The presence of tense ascites can indicate elevated intra-abdominal pressure that can retard renal venous return and result in AKI.
The presence of an epigastric bruit suggests renal vascular hypertension, which may predispose to AKI.
Pulmonary
Pulmonary examination may reveal the following:
- Rales - Goodpasture syndrome, Wegener granulomatosis
- Hemoptysis - Wegener granulomatosis
Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. Jul 2004;114(1):5-14. [Medline]. [Full Text].
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. Aug 2004;8(4):R204-12. [Medline]. [Full Text].
[Best Evidence] Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. Mar 2009;110(3):505-15. [Medline].
Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis. Jul 2008;15(3):297-307. [Medline].
Feest TG, Mistry CD, Grimes DS, Mallick NP. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. BMJ. Oct 20 1990;301(6757):897-900. [Medline]. [Full Text].
Pannu N, James M, Hemmelgarn BR, Dong J, Tonelli M, Klarenbach S. Modification of Outcomes After Acute Kidney Injury by the Presence of CKD. Am J Kidney Dis. Aug 2011;58(2):206-13. [Medline].
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid Balance, Diuretic Use, and Mortality in Acute Kidney Injury. Clin J Am Soc Nephrol. May 2011;6(5):966-973. [Medline]. [Full Text].
James MT, Hemmelgarn BR, Wiebe N, Pannu N, Manns BJ, Klarenbach SW, et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet. Dec 18 2010;376(9758):2096-103. [Medline].
Molnar AO, Coca SG, Devereaux PJ, Jain AK, Kitchlu A, Luo J, et al. Statin use associates with a lower incidence of acute kidney injury after major elective surgery. J Am Soc Nephrol. May 2011;22(5):939-46. [Medline]. [Full Text].
American College of Radiology. ACR Appropriateness Criteria® renal failure. National Guideline Clearinghouse. Available at http://guideline.gov/content.aspx?id=13685. Accessed March 24, 2011.
Breidthardt T, Christ-Crain M, Stolz D, et al. A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections. Am J Med. Feb 2012;125(2):168-75. [Medline].
Hall IE, Coca SG, Perazella MA, et al. Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis. Clin J Am Soc Nephrol. Dec 2011;6(12):2740-9. [Medline].
Mancini E, Caramelli F, Ranucci M, et al. Is time on cardiopulmonary bypass during cardiac surgery associated with acute kidney injury requiring dialysis?. Hemodial Int. Nov 8 2011;[Medline].
[Best Evidence] Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. Jul 3 2008;359(1):7-20. [Medline]. [Full Text].
[Best Evidence] Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. Jun 29 2006;354(26):2773-82. [Medline].
[Best Evidence] Ho KM, Morgan DJ. Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. Am J Kidney Dis. Jan 2009;53(1):33-40. [Medline].
[Best Evidence] Zacharias M, Conlon NP, Herbison GP, Sivalingam P, Walker RJ, Hovhannisyan K. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. Oct 8 2008;CD003590. [Medline].
| Stage | GFR** Criteria | Urine Output Criteria | Probability |
| Risk | SCreat† increased × 1.5 or GFR decreased >25% | UO‡ < 0.5 mL/kg/h × 6 h | High sensitivity (Risk >Injury >Failure) |
| Injury | SCreat increased × 2 or GFR decreased >50% | UO < 0.5 mL/kg/h × 12 h | |
| Failure | SCreat increased × 3 or GFR decreased 75% or SCreat ≥4 mg/dL; acute rise ≥0.5 mg/dL | UO < 0.3 mL/kg/h × 24 h (oliguria) or anuria × 12 h | |
| Loss | Persistent acute renal failure: complete loss of kidney function >4 wk | High specificity | |
| ESKD* | Complete loss of kidney function >3 mo | ||
| *ESKD—end-stage kidney disease; **GFR—glomerular filtration rate; †SCreat—serum creatinine; ‡UO—urine output Note: Patients can be classified by GFR criteria and/or UO criteria. The criteria that support the most severe classification should be used. The superimposition of acute on chronic failure is indicated with the designation RIFLE-FC; failure is present in such cases even if the increase in SCreat is less than 3-fold, provided that the new SCreat is greater than 4.0 mg/dL (350 μmol/L) and results from an acute increase of at least 0.5 mg/dL (44 μmol/L). | |||

